Cycling chemotherapy: A promising approach to reducing the morbidity and mortality of nosocomial infections

Drugs of Today

Volumn 39, Issue 9, 2003, Pages 733-738

  Evans, Heather L ^a,b   Sawyer, Robert G ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b Building MR 4 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; AUTOMATION; CHEMOTHERAPY; CYCLING CHEMOTHERAPY; DRUG USE; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; INFECTION CONTROL; MATHEMATICAL MODEL; MORBIDITY; MORTALITY; PREVALENCE; RISK FACTOR; THEORY;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY; HUMANS; MORBIDITY; UNITED STATES;

EID: 0242595611     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2003.39.9.799480     Document Type: Article

References (34)

1. Waterer, G.W., Wunderink, R.G. Increasing threat of Gram-negative bacteria. Crit Care Med 2001, 29: N75-81.
2. Niederman, M.S. Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med 2001, 29: N114-20.
3. Song, X., Srinivasan, A., Plaut, D., Perl, T.M. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol 2003, 24: 251-6.
4. Hecker, M.T., Aron, D.C., Patel, N.P., Lehmann, M.K., Donskey, C.J. Unnecessary use of antimicrobials in hospitalized patients: Current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003, 163: 972-8.
5. McGowan, J.E., Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983, 5: 1033-48.
6. Kollef, M.H., Sherman, G., Ward, S., Fraser, V.J. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999, 115: 462-74.
7. May, A.K., Melton, S.M., McGwin, G., Cross, J.M., Moser, S.A., Rue, L.W. Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and bum intensive care unit. Shock 2000, 14: 259-64.
8. Quale, J., Landman, D., Saurina, G., Atwood, E., DiTore, V., Patel, K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996, 23: 1020-5.
9. Rahal, J.J., Urban, C., Horn, D. et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998, 280: 1233-7.
10. Bailey, T.C., Troy McMullin, S. Using information systems technology to improve antibiotic prescribing. Crit Care Med 2001, 29: N87-91.
11. Evans, R.S., Pestotnik, S.L., Classen, D.C. et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998, 338: 232-8.
12. Singh, N., Rogers, P., Atwood, C.W., Wagener, M.M., Yu, V.L. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000, 162: 505-11.
13. Paterson, D.L., Rice, L.B. Empirical antibiotic choice for the seriously ill patient: Are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive? Clin Infect Dis 2003, 36: 1006-12.
14. Bonhoeffer, S., Lipsitch, M., Levin, B.R. Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA 1997, 94: 12106-11.
15. Lipsitch, M., Bergstrom, C.T., Levin, B.R. The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions. Proc Natl Acad Sci USA 2000, 97: 1938-43.
16. Ruiz-Palacios, G.M., Ponce de Leon, S., Sifuentes, J. et al. Control of emergence of multiresistant gram-negative bacilli by exclusive use of amikacin. Am J Med 1986, 80: 71-5.
17. Young, E.J., Sewell, C.M., Koza, M.A., Clarridge, J.E. Antibiotic resistance patterns during aminoglycoside restriction. Am J Med Sci 1985, 290: 223-7.
18. Betts, R.F., Valenti, W.M., Chapman, S.W. et al. Five-year surveillance of aminoglycoside usage in a university hospital. Ann Intern Med 1984, 100: 219-22.
19. Gerding, D.N., Larson, T.A. Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center. Am J Med 1985, 79: 1-7.
20. Gerding, D.N., Larson, T.A., Hughes, R.A., Weiler, M., Shanholtzer, C., Peterson, L.R. Aminoglycoside resistance and aminoglycoside usage: Ten years of experience in one hospital. Antimicrob Agents Chemother 1991, 35: 1284-90.
21. Kollef, M.H., Vlasnik, J., Sharpless, L., Pasque, C., Murphy, D., Fraser, V. Scheduled change of antibiotic classes: A strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997, 156: 1040-8.
22. Kollef, M.H., Ward, S., Sherman, G. et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med 2000, 28: 3456-64.
23. Puzniak, L.A., Mayfield, J., Leet, T., Kollef, M., Mundy, L.M. Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit. Clin Infect Dis 2001, 33: 151-7.
24. Gruson, D., Hilbert, G., Vargas, F. et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am J Respir Crit Care Med 2000, 162: 837-43.
25. Allegranzi, B., Luzzati, R., Luzzani, A. et al. Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections. J Hosp Infect 2002, 52: 136-40.
26. Raymond, D.P., Pelletier, S.J., Crabtree, T.D. et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive unit. Crit Care Med 2001, 29: 1001-8
27. Allegranzi, B., Gottin, L., Bonora, S., Zanoni, L., Ischia, S., Concia, E. Antibiotic rotation in intensive care units: Its usefulness should be demonstrated without pitfalls. Crit Care Med 2002, 30: 2170-1.
28. Evans, H.L., Hughes, M.G., Chong, T.W. et al. Comparison of dual-versus single-antibiotic rotation strategies in an intensive care unit. Surg Infections 2002, 3: Abst. 45.
29. Evans, H.L., Milburn, M.L., Hughes, M.G. et al. Nature of GNR antibiotic resistance in antibiotic rotation. Surg Infections 2003, 4: Abst. 4.
30. Bochorishvili, V., Madariaga, M.G., Pur, S., Weinstein, R., Segreti, J. Reasons for non-compliance with voluntary cycling of antibiotics. 40th Annual Meeting of the Infectious Disease Society of America (Alexandria, VA) 2002, Abst. 109.
31. Shlaes, D.M., Gerding, D.N., John, J.F., Jr. et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997, 25: 584-99.
32. Toltzis, P., Dul, M.J., Hoyen, C. et al. The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit. Pediatrics 2002, 110: 707-11.
33. Hughes, M.G., Raymond, D.P., Evans, H.L. et al. Impact of an ICU rotating empiric antibiotic schedule on the development of infections on the non-ICU ward. Crit Care Med 2003, In press.
34. McGowan, J.E., Jr. Strategies for study of the role of cycling on antimicrobial use and resistance. Infect Control Hosp Epidemiol 2000, 21: S36-43.